You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
內地擬成立生物醫藥產業工作組 推進生物醫藥產業數字化轉型
據《證券時報》報道,中國人工智能產業發展聯盟(AIIA)擬發起成立「生物醫藥產業工作組」。工作組旨在聯合開展人工智能+生物醫藥前沿技術與產業發展研究,開展標準研製和監管科學研究工作,發揮聯盟的資源整合優勢,促進跨界交流合作,推進生物醫藥產業數字化轉型,加快未來技術創新和未來健康產業發展。 為把握生物醫藥產業與人工智能技術融合發展機遇,該工作組將開展AI製藥及生物醫藥大模型標準研製和評估驗證工作,建設基準數據集和測評平台、工具等,加快大模型及其他AI技術在生物科研、藥械研發、臨床試驗、註冊審評、生產製造、供應流通、數字化營銷、用戶使用和服務等關鍵環節快速合規地落地應用。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account